US Patent Number
Niacin and niacin prodrugs are topically administered as suitable formulations to device for impoving the lipid profiles of subjects, preferably humans.
University of Kentucky Research Foundation, Lexington, KY (US)
Jacobson, Elaine L.; Jacobson, Myron; Kim, Hyuntae; Kim, Moonsun; and Qasem, Jaber G., "Topical Formulations for the Transdermal Delivery of Niacin and Methods of Treating Hyperlipidemia" (2004). Graduate Center for Nutritional Sciences Faculty Patents. 14.